Restoring Balance: What the FDA's Peptide Announcement Could Mean for Patient Access and Safety Empower Pharmacy FDA IS REPORTEDLY EXPECTED TO LIFT RESTRICTION ON PEPTIDES NYT HIMS $LLY $NVO The FDA will discuss 7 peptides for possible inclusion on the 503A Bulks List on July 23 24: BPC 157 KPV TB 500 MOTs C Emideltide Semax FDA Peptide Reclassification 2026: What Researchers Want